Snowden Capital Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,299	Closed	-$407K	–	683
2020 Q3	$407K	Buy	2,299 +236	+11%	+$41.8K	0.03%	425
2020 Q2	$477K	Hold	2,063	–	–	0.04%	383
2020 Q1	$240K	Buy	2,063 +12	+0.6%	+$1.4K	0.03%	468
2019 Q4	$392K	Buy	+2,051	New	+$392K	0.03%	435